MyAverix Finance
SHG · Healthcare
Guangxi Liuzhou Pharm Co Ltd (603368)
Medical Distribution
Guangxi Liuzhou Pharm Co Ltd (603368) is listed on SHG in the Healthcare sector. Industry: Medical Distribution. As of 2026-03-29, reported market cap is $6.66B, P/E ratio is 8.51, net margin is 3.8%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 603368
Guangxi Liuzhou Pharm Co Ltd (603368) — FAQ
What is Guangxi Liuzhou Pharm Co Ltd's market cap?
Guangxi Liuzhou Pharm Co Ltd (603368) has a reported market cap of $6.66B (data as of 2026-03-29).
What is 603368's P/E ratio?
The price-to-earnings (P/E) ratio for Guangxi Liuzhou Pharm Co Ltd (603368) is 8.51 (data as of 2026-03-29).
Does Guangxi Liuzhou Pharm Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Guangxi Liuzhou Pharm Co Ltd (603368). Check the MyAverix Finance app for the latest dividend data.
What sector is Guangxi Liuzhou Pharm Co Ltd in?
Guangxi Liuzhou Pharm Co Ltd (603368) is classified in the Healthcare sector (Medical Distribution industry).
What exchange is 603368 listed on?
603368 is listed on SHG.
What is Guangxi Liuzhou Pharm Co Ltd's net margin?
Guangxi Liuzhou Pharm Co Ltd (603368) reports a net margin of 3.8% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.